Revenue
97.2 thousand USD
2025 Q3 · USD
Exact inputs and evidence
- Revenue: 97235 USD Source
Market value is not computed: no recent price is available.
121 filing records in this dataset, filed from 2003-04-17 to 2025-08-12. Reported financial figures are available; chart coverage varies by period.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
This issuer has insider filings in the store, but no transaction in this window or code group.
These figures cover less than a full year. They are not annualized and are excluded from full-year trends and comparisons.
97.2 thousand USD
2025 Q3 · USD
-68.48%
2025 Q3 · %
-124 thousand USD
2025 Q3 · USD
3016 USD
407071028 shares
0.25% · 1 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
97.2 thousand USD
2024-01-01 – 2024-12-31
-1.04 million USD
2024-01-01 – 2024-12-31
-506 thousand USD
2024-01-01 – 2024-12-31
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2025-08-12.
Financial data available through: 2024-03-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 0
–
Current period
USD 0
–
0 − 0 = 0 USD
0 USD · 2022-04-01 – 2023-03-31
Inspect prior input Prior source0 USD · 2023-04-01 – 2024-03-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 4.13 million
–
Current period
−USD 1.36 million
–
-1361677 − -4125194 = 2763517 USD
-4125194 USD · 2022-04-01 – 2023-03-31
Inspect prior input Prior source-1361677 USD · 2023-04-01 – 2024-03-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 1.53 million
–
Current period
−USD 975,698
–
-975698 − -1526861 = 551163 USD
-1526861 USD · 2022-04-01 – 2023-03-31
Inspect prior input Prior source-975698 USD · 2023-04-01 – 2024-03-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2016 2015-04-01 – 2016-03-31 | 0 | 6958769 Derived | -6958769 | -187434 Derived | -6771335 | -4445603 Derived | Source
|
| 2017 2016-04-01 – 2017-03-31 | 0 | 8933111 Derived | -8933111 | 976719 Derived | -9909830 | -7521265 Derived | Source
|
| 2018 2017-04-01 – 2018-03-31 | 2510364 | 20335015 Derived | -17824651 | 5149539 Derived | -22974190 | -15677745 Derived | Source
|
| 2019 2018-04-01 – 2019-03-31 | 3454552 | 16645621 Derived | -13191069 | 10462096 Derived | -23653165 | -11367989 Derived | Source
|
| 2020 2019-04-01 – 2020-03-31 | 0 | 5741514 Derived | -5741514 | 6632065 Derived | -12373579 | -4682010 Derived | Source
|
| 2021 2020-04-01 – 2021-03-31 | 0 | 2001617 Derived | -2001617 | 1723410 Derived | -3725027 | Unavailable | Source
|
| 2022 2021-04-01 – 2022-03-31 | 0 | 1868734 Derived | -1868734 | -1337861 Derived | -530873 | Unavailable | Source
|
| 2023 2022-04-01 – 2023-03-31 | 0 | 1672281 Derived | -1672281 | 2452913 Derived | -4125194 | Unavailable | Source
|
| 2024 2023-04-01 – 2024-03-31 | 0 | 1420509 Derived | -1420509 | -58832 Derived | -1361677 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Revenue | 0 |
|
| 2017 | Revenue | 0 |
|
| 2018 | Revenue | 2510364 |
|
| 2019 | Revenue | 3454552 |
|
| 2020 | Revenue | 0 |
|
| 2021 | Revenue | 0 |
|
| 2022 | Revenue | 0 |
|
| 2023 | Revenue | 0 |
|
| 2024 | Revenue | 0 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Year over year | No prior comparable period |
|
| 2017 | Year over year | No prior comparable period |
|
| 2018 | Year over year | No prior comparable period |
|
| 2019 | Year over year | 37.6% |
|
| 2020 | Year over year | -100% |
|
| 2021 | Year over year | No prior comparable period |
|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | No prior comparable period |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Operating margin | Not reported |
|
| 2017 | Operating margin | Not reported |
|
| 2018 | Operating margin | -710% |
|
| 2019 | Operating margin | -381.8% |
|
| 2020 | Operating margin | Not reported |
|
| 2021 | Operating margin | Not reported |
|
| 2022 | Operating margin | Not reported |
|
| 2023 | Operating margin | Not reported |
|
| 2024 | Operating margin | Not reported |
|
| 2016 | Net margin | Not reported |
|
| 2017 | Net margin | Not reported |
|
| 2018 | Net margin | -915.2% |
|
| 2019 | Net margin | -684.7% |
|
| 2020 | Net margin | Not reported |
|
| 2021 | Net margin | Not reported |
|
| 2022 | Net margin | Not reported |
|
| 2023 | Net margin | Not reported |
|
| 2024 | Net margin | Not reported |
|
| 2016 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | Not reported |
|
| 2018 | Free cash flow margin | -624.5% |
|
| 2019 | Free cash flow margin | -329.1% |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Operating cash flow | -3564008 |
|
| 2017 | Operating cash flow | -4468995 |
|
| 2018 | Operating cash flow | -12247994 |
|
| 2019 | Operating cash flow | -9855895 |
|
| 2020 | Operating cash flow | -4479713 |
|
| 2021 | Operating cash flow | -2185220 |
|
| 2022 | Operating cash flow | -1866154 |
|
| 2023 | Operating cash flow | -1526861 |
|
| 2024 | Operating cash flow | -975698 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Free cash flow | -4445603 |
|
| 2017 | Free cash flow | -7521265 |
|
| 2018 | Free cash flow | -15677745 |
|
| 2019 | Free cash flow | -11367989 |
|
| 2020 | Free cash flow | -4682010 |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Liabilities / assets | 181.1% |
|
| 2017 | Liabilities / assets | 35.4% |
|
| 2018 | Liabilities / assets | 35% |
|
| 2019 | Liabilities / assets | 42.9% |
|
| 2020 | Liabilities / assets | 100.6% |
|
| 2021 | Liabilities / assets | 113.6% |
|
| 2022 | Liabilities / assets | 169.9% |
|
| 2023 | Liabilities / assets | 1,350.9% |
|
| 2024 | Liabilities / assets | 5,237.3% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Current assets / current liabilities | 0.09× |
|
| 2017 | Current assets / current liabilities | 4.36× |
|
| 2018 | Current assets / current liabilities | 3.78× |
|
| 2019 | Current assets / current liabilities | 0.52× |
|
| 2020 | Current assets / current liabilities | 0.64× |
|
| 2021 | Current assets / current liabilities | 0.41× |
|
| 2022 | Current assets / current liabilities | 0.08× |
|
| 2023 | Current assets / current liabilities | 0.07× |
|
| 2024 | Current assets / current liabilities | 0.02× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2015 2014-04-01 – 2015-03-31 | −USD 7.72 million Exact valueExact value: -7722755 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.5 million Exact valueExact value: -3502623 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 937,660 Exact valueExact value: 937660 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.44 million Calculation and evidence-3502623 − 937660 USD Exact free cash flow: -4440283 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2016 2015-04-01 – 2016-03-31 | −USD 6.77 million Exact valueExact value: -6771335 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.56 million Exact valueExact value: -3564008 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 881,595 Exact valueExact value: 881595 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.45 million Calculation and evidence-3564008 − 881595 USD Exact free cash flow: -4445603 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2017 2016-04-01 – 2017-03-31 | −USD 9.91 million Exact valueExact value: -9909830 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.47 million Exact valueExact value: -4468995 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.05 million Exact valueExact value: 3052270 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.52 million Calculation and evidence-4468995 − 3052270 USD Exact free cash flow: -7521265 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2017-04-01 – 2018-03-31 | −USD 22.97 million Exact valueExact value: -22974190 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.25 million Exact valueExact value: -12247994 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.43 million Exact valueExact value: 3429751 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 15.68 million Calculation and evidence-12247994 − 3429751 USD Exact free cash flow: -15677745 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2018-04-01 – 2019-03-31 | −USD 23.65 million Exact valueExact value: -23653165 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.86 million Exact valueExact value: -9855895 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.51 million Exact valueExact value: 1512094 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 11.37 million Calculation and evidence-9855895 − 1512094 USD Exact free cash flow: -11367989 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2019-04-01 – 2020-03-31 | −USD 12.37 million Exact valueExact value: -12373579 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.48 million Exact valueExact value: -4479713 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 202,297 Exact valueExact value: 202297 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.68 million Calculation and evidence-4479713 − 202297 USD Exact free cash flow: -4682010 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2020-04-01 – 2021-03-31 | −USD 3.73 million Exact valueExact value: -3725027 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.19 million Exact valueExact value: -2185220 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2021-04-01 – 2022-03-31 | −USD 530,873 Exact valueExact value: -530873 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.87 million Exact valueExact value: -1866154 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2022-04-01 – 2023-03-31 | −USD 4.13 million Exact valueExact value: -4125194 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.53 million Exact valueExact value: -1526861 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2023-04-01 – 2024-03-31 | −USD 1.36 million Exact valueExact value: -1361677 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 975,698 Exact valueExact value: -975698 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
121 filings · 3,179 latest values · 3,207 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001165320, 1165320, GBLX, edgar:1165320, gblx, sxlp
Also known as Diabetic Treatment Centers of America, Inc., FLAGSTICK VENTURES INC, GB SCIENCES INC, Growblox Sciences, Inc., Signature Exploration & Production Corp.